Ethinyl estradiol and desogestrel and Ibritumomab
Determining the interaction of Ethinyl estradiol and desogestrel and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desogestrel / ethinyl estradiol
Brand name: Azurette, Cyclessa, Desogen, Isibloom, Kariva, Mircette, Reclipsen, Cyred
Synonyms: Ethinyl Estradiol and Desogestrel
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethinyl estradiol and desogestrel-Ibritumomab Intravenous
- Ethinyl estradiol and desogestrel-Ibritumomab Tiuxetan
- Ethinyl estradiol and desogestrel-Ibrutinib
- Ethinyl estradiol and desogestrel-Ibrutinib Capsules
- Ethinyl estradiol and desogestrel-Ibrutinib Tablets
- Ethinyl estradiol and desogestrel-Ibu
- Ibritumomab-Ethinyl Estradiol and Drospirenone
- Ibritumomab-Ethinyl estradiol and ethynodiol diacetate
- Ibritumomab-Ethinyl Estradiol and Etonogestrel
- Ibritumomab-Ethinyl estradiol and etonogestrel Vaginal
- Ibritumomab-Ethinyl estradiol and etonogestrel vaginal ring
- Ibritumomab-Ethinyl estradiol and levonorgestrel